KevinMD.com: Social media’s leading physician voice
The KevinMD newsletterReal physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →
NEWExperts by KevinMDPhysicians and health care experts, by specialty.Shveta GuptaHematology physicianDevin ZarkowskyVascular surgeonKenneth RoInternistEmily WattersPsychiatristAleksandra FilipovicMedical oncologistReuben MathewMed-peds residentRobert MurryFamily physicianKayvan HaddadanPhysiatristPaul HainPediatricianBarbara SparacinoPsychiatristHussain Isma'eelCardiologistAnn LebeckFamily physicianLynn R. WebsterPain medicine physicianAngelika LuehrsConsultant psychiatristBobby DuboisInternistLaurel A. CoonsScientistNathaniel AranaHealth care CEOCraig HaubenHealth care CEOJessica ChalkPatient advocateBrowse experts

Pfizer and Merck: Different Strokes

Pfizer and Merck: Different Strokes

“Celebrex continues to sell, while Vioxx got yanked. Courts, doctors, patients, and investors will decide which approach is better.”

Indeed. For how long Celebrex continues to sell is another question.

Share this articleLinkedInFacebookXEmail

Tagged as: Patients

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.

Keep reading

Latest on KevinMD →

Leave a Comment
KevinMD.com
Pfizer and Merck: Different Strokes